2005
DOI: 10.2106/jbjs.d.01896
|View full text |Cite
|
Sign up to set email alerts
|

Botulinum Toxin Injection in the Treatment of Tennis Elbow

Abstract: With the numbers studied, we failed to find a significant difference between the two groups; thus, we have no evidence of a benefit from botulinum toxin injection in the treatment of chronic tennis elbow.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
19
0
1

Year Published

2007
2007
2018
2018

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 88 publications
(20 citation statements)
references
References 9 publications
0
19
0
1
Order By: Relevance
“…The unaffected arm served as a control. We used a dynamometer to measure grip strength in kilograms with the upper limb in a standardized position as recommended in a studies of elbow position and grip strength ( 17 , 18 ). The upper limb was positioned in a supine lying position; the palm of the hand was placed flat on the treatment table and adjacent to the subject’s side.…”
Section: Methodsmentioning
confidence: 99%
“…The unaffected arm served as a control. We used a dynamometer to measure grip strength in kilograms with the upper limb in a standardized position as recommended in a studies of elbow position and grip strength ( 17 , 18 ). The upper limb was positioned in a supine lying position; the palm of the hand was placed flat on the treatment table and adjacent to the subject’s side.…”
Section: Methodsmentioning
confidence: 99%
“…Complete return of function occurs by 6 months. 4 Botulinum toxin A is considered safe and effective for the treatment of movement disorders and spasticity, and it has been widely used in both pediatric and adult orthopaedics for spasticity in cerebral palsy, 1,5,6,9,19,22,27 in idiopathic clubfoot, 2,26 in the pectoralis major muscle in irreducible shoulder dislocations, 29 in tennis elbow, 16,20,35 and in flexor tendon repairs in children. 33 Tuzuner et al 33 used botulinum toxin A during surgery to induce forearm flexor relaxation in children aged under 6 years with zone 2 flexor tendon repairs.…”
mentioning
confidence: 99%
“…Hayton et al studied 40 patients with refractory tennis elbow pain with a duration of over 6 months, who had experienced no pain relief from ≥1 corticosteroid injections and a full course of physiotherapy 77 ( Table 2). Patients were randomized to either 50 units of botulinum toxin type A (Allergan; n=19) or normal saline placebo (2 ml; n=21) injected 5cm distal to the area of maximal tenderness at the lateral epicondyle 77 ( Table 2).…”
Section: Tennis Elbowmentioning
confidence: 99%
“…Patients were randomized to either 50 units of botulinum toxin type A (Allergan; n=19) or normal saline placebo (2 ml; n=21) injected 5cm distal to the area of maximal tenderness at the lateral epicondyle 77 ( Table 2). There were no statistically significant differences in pain between the botulinum toxin and placebo groups at 3 months after the injection (difference of 1.1 between groups, p = 0.54), grip strength (difference of 0.57 kg between groups, p = 0.90), or quality of life measured by the Short Form-12 physical (difference of 6.24 points between groups, p = 0.16) and mental (difference of 4.26 points between groups, p = 0.42) component summary scores.…”
Section: Tennis Elbowmentioning
confidence: 99%